Loading organizations...
§ Private Profile · Palo Alto, CA, USA
Fintech platform providing credit, commerce, and payment solutions for pharma retail and distribution in India, optimizing working capital.
Fundly has raised $7.0M across 2 funding rounds.
Key people at Fundly.
Fundly has raised $7.0M in total across 2 funding rounds.
Fundly is a Mumbai, India-based financial technology platform that provides integrated credit, commerce, and payment solutions specifically designed for the pharmaceutical retail and distribution sector. The company facilitates supply chain financing and enterprise resource planning-integrated payments to help small businesses optimize working capital and digitize their daily operational workflows. Operating across more than twenty-four cities and six hundred postal codes, the platform serves a rapidly growing network of pharmaceutical supply chain participants. The organization currently maintains a workforce of 33 employees and has successfully onboarded over 4,100 retailers and distributors to its digital ecosystem. To date, the enterprise has disbursed over ₹1,093 crore in total funds to support micro, small, and medium enterprises within the broader healthcare industry. Fundly was established in early 2021 by two unnamed entrepreneurs with over forty years of combined industry experience.
Fundly has raised $7.0M across 2 funding rounds. Most recently, it raised $5.0M Other Equity in September 2011.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 28, 2011 | $5M Venture Round | Mark Goines, Mark Goines | Accelerator Ventures, Correlation Ventures, Kapor Capital, Seraph Group | Announced |
| Feb 1, 2011 | $2M Seed | — | AgFunder, Bessemer Venture Partners, K5 Ventures, Khosla Ventures, M34 Capital, NFX, Sound Ventures, Tugboat Ventures, Chris YEH, Eric Ries, Mark Goines, Shervin Pishevar, Troy Carter, Brad Gerstner, Christopher Muenchhoff, Christoph Janz, Clayton Christensen, Dave Kashen, Geoff Ralston, James Currier, Jason Henrichs, Karl Jacob, Keith Rabois, Ronald Conway, Jeff Fluhr, Trevor Kienzle, George Zachary, Stephen Deberry | Announced |
Fundly.ai is a fintech platform tailored for India's pharmaceutical sector, providing integrated solutions in credit, commerce, and payments to pharma suppliers, distributors, and retailers. It addresses inefficiencies in cash flow, purchasing, and financing by offering unsecured working capital, seamless system integrations, and tools for better margins and negotiations, enabling sustainable growth for small businesses in the healthcare supply chain[1].
The platform serves pharmacy owners and distributors facing challenges like delayed payments and limited credit access, streamlining operations to make pharma businesses more digital, efficient, and scalable. Testimonials highlight its impact, such as enabling timely financing to secure distributor discounts, positioning Fundly.ai as a key enabler in India's pharma retail ecosystem[1].
Specific founding details for Fundly.ai, such as founders or exact launch year, are not detailed in available sources. The company emerged to tackle longstanding pain points in India's pharma industry, like fragmented credit and payment cycles, by building a dedicated digital ecosystem[1].
Early traction is evident from user feedback, where pharmacy owners report transformative improvements in financing access and business negotiations pre- and post-Fundly.ai adoption, signaling rapid validation in a high-volume, low-margin sector[1].
Fundly.ai rides the wave of fintech digitization in India's healthcare supply chain, where pharma retail—a $20B+ fragmented market—grapples with cash flow issues amid rising demand post-pandemic. Timing aligns with government pushes for digital payments (e.g., UPI expansion) and credit inclusion for SMEs, amplified by market forces like supply chain disruptions and e-pharma growth[1].
It influences the ecosystem by empowering the "backbone" of healthcare—small retailers and distributors—driving efficiency that scales to national levels, potentially reducing costs and improving medicine access in underserved areas[1].
Fundly.ai is poised to expand as India's pharma sector digitizes further, with trends like AI-driven credit scoring and embedded finance accelerating adoption. Regulatory tailwinds for digital lending and pharma consolidation will shape its path, potentially growing its network into a dominant platform[1].
Its influence may evolve from niche enabler to ecosystem leader, integrating deeper with distributors and expanding beyond India if it sustains user momentum—ultimately fueling scalable success for pharma's underserved players[1].
Fundly has raised $7.0M in total across 2 funding rounds.
Fundly's investors include Mark Goines, Accelerator Ventures, Correlation Ventures, Kapor Capital, Seraph Group, AgFunder, Bessemer Venture Partners, K5 Ventures, Khosla Ventures, M34 Capital, NFX, Sound Ventures.
Key people at Fundly.
